Correlation Between Pfizer and JPMorgan BetaBuilders

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and JPMorgan BetaBuilders at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and JPMorgan BetaBuilders into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and JPMorgan BetaBuilders Small, you can compare the effects of market volatilities on Pfizer and JPMorgan BetaBuilders and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of JPMorgan BetaBuilders. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and JPMorgan BetaBuilders.

Diversification Opportunities for Pfizer and JPMorgan BetaBuilders

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and JPMorgan is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and JPMorgan BetaBuilders Small in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on JPMorgan BetaBuilders and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with JPMorgan BetaBuilders. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of JPMorgan BetaBuilders has no effect on the direction of Pfizer i.e., Pfizer and JPMorgan BetaBuilders go up and down completely randomly.

Pair Corralation between Pfizer and JPMorgan BetaBuilders

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the JPMorgan BetaBuilders. In addition to that, Pfizer is 1.02 times more volatile than JPMorgan BetaBuilders Small. It trades about -0.16 of its total potential returns per unit of risk. JPMorgan BetaBuilders Small is currently generating about 0.32 per unit of volatility. If you would invest  6,657  in JPMorgan BetaBuilders Small on September 1, 2024 and sell it today you would earn a total of  797.00  from holding JPMorgan BetaBuilders Small or generate 11.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Pfizer Inc  vs.  JPMorgan BetaBuilders Small

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
JPMorgan BetaBuilders 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan BetaBuilders Small are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, JPMorgan BetaBuilders exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and JPMorgan BetaBuilders Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and JPMorgan BetaBuilders

The main advantage of trading using opposite Pfizer and JPMorgan BetaBuilders positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, JPMorgan BetaBuilders can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in JPMorgan BetaBuilders will offset losses from the drop in JPMorgan BetaBuilders' long position.
The idea behind Pfizer Inc and JPMorgan BetaBuilders Small pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
CEOs Directory
Screen CEOs from public companies around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets